TY - JOUR
T1 - The feasibility and acceptability of outdoor sessions as an add-on of an online multicomponent program (FIBROWALK) for fibromyalgia
T2 - A pilot randomized controlled trial
AU - Serrat, Mayte
AU - Navarrete, Jaime
AU - Rodríguez-Freire, Carla
AU - Royuela-Colomer, Estíbaliz
AU - Almirall, Miriam
AU - Nieto, Rubén
AU - Montero-Marín, Jesús
AU - Luciano, Juan V.
AU - Feliu-Soler, Albert
N1 - Publisher Copyright:
© 2025 Sociedad Española de Reumatología (SER), Colegio Mexicano de Reumatología (CMR) y Elsevier España, S.L.U.
PY - 2025/3/1
Y1 - 2025/3/1
N2 - Introduction and objectives: The given text describes a pilot randomized controlled trial aimed at evaluating the feasibility and acceptability of outdoor sessions as an add-on to an online multicomponent program (FIBROWALK) for fibromyalgia (FM) patients. Materials and methods: The trial involved 110 participants with FM (99% women; mean age of 51.89 ± 1.89 years) from a tertiary hospital in Spain who were randomly assigned to either the online FIBROWALK program (n = 38) or the blended FIBROWALK program arm (n = 61; online FIBROWALK plus 4 outdoor sessions). Results: Overall, attrition was minimal (14.01%) and adherence to the outdoor session was modest (52% of the group attended at least one outdoor session). Participants’ expectations and opinions were positive. Paired-samples t-tests for examining within-group differences showed that participants in each arm had significantly improved functional impairment, anxious-depressive symptomatology, physical function, and fear of pain symptoms. Analysis of covariance for examining between-group differences showed that the blended FIBROWALK had a significantly higher effect on psychological distress than the online FIBROWALK (F(1,96) = 4.23; p =.042; Cohen's d =.60). Conclusions: These results suggest that the blended program was feasible, secure, and acceptable to the participants. Although the online FIBROWALK program alone may be sufficient for managing fibromyalgia symptoms, the addition of outdoor sessions may provide significant additional benefits. Future definitive randomized controlled trials are warranted.
AB - Introduction and objectives: The given text describes a pilot randomized controlled trial aimed at evaluating the feasibility and acceptability of outdoor sessions as an add-on to an online multicomponent program (FIBROWALK) for fibromyalgia (FM) patients. Materials and methods: The trial involved 110 participants with FM (99% women; mean age of 51.89 ± 1.89 years) from a tertiary hospital in Spain who were randomly assigned to either the online FIBROWALK program (n = 38) or the blended FIBROWALK program arm (n = 61; online FIBROWALK plus 4 outdoor sessions). Results: Overall, attrition was minimal (14.01%) and adherence to the outdoor session was modest (52% of the group attended at least one outdoor session). Participants’ expectations and opinions were positive. Paired-samples t-tests for examining within-group differences showed that participants in each arm had significantly improved functional impairment, anxious-depressive symptomatology, physical function, and fear of pain symptoms. Analysis of covariance for examining between-group differences showed that the blended FIBROWALK had a significantly higher effect on psychological distress than the online FIBROWALK (F(1,96) = 4.23; p =.042; Cohen's d =.60). Conclusions: These results suggest that the blended program was feasible, secure, and acceptable to the participants. Although the online FIBROWALK program alone may be sufficient for managing fibromyalgia symptoms, the addition of outdoor sessions may provide significant additional benefits. Future definitive randomized controlled trials are warranted.
KW - Blended treatment
KW - Fibromyalgia
KW - FIBROWALK
KW - Multicomponent intervention
KW - Online
KW - Fibrowalk
UR - http://www.scopus.com/inward/record.url?scp=85219149542&partnerID=8YFLogxK
UR - https://www.mendeley.com/catalogue/b3f005a2-9568-36d5-8356-3a0b7f5abaf6/
U2 - 10.1016/j.reuma.2025.501817
DO - 10.1016/j.reuma.2025.501817
M3 - Article
AN - SCOPUS:85219149542
SN - 1699-258X
VL - 21
JO - Reumatologia Clinica
JF - Reumatologia Clinica
IS - 3
M1 - 501817
ER -